Publications by Dr Florence Burte - ePrints

Browsing publications by Dr Florence Burte.

Newcastle Authors	Title	Year
Dr Florence Burte	OPA1 disease-causing mutants have domain-specific effects on mitochondrial ultrastructure and fusion	2023
Dr Marzena Kurzawa-Akanbi Dr Florence Burte Dr Birthe Hilgen Dr Rachel Queen Dr Jonathan Coxhead et al.	Retinal pigment epithelium extracellular vesicles are potent inducers of age-related macular degeneration disease phenotype in the outer retina	2022
Dr Florence Burte Dr Holly Duncan Professor Patrick Chinnery	WFS1-Associated Optic Neuropathy: Genotype-Phenotype Correlations and Disease Progression	2022
George Cairns Dr Florence Burte Emily O'Connor Dr Angela Pyle Professor John Sayer et al.	A mutant wfs1 zebrafish model of Wolfram syndrome manifesting visual dysfunction and developmental delay	2021
Dr Marzena Kurzawa-Akanbi Rachel Heap Professor Matthias Trost Dr Preeti Singh Dr Florence Burte et al.	Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders	2021
Dr Florence Burte	Depleted circulatory complement-lysis inhibitor (CLI) in childhood cerebral malaria returns to normal with convalescence	2021
Dr Florence Burte Dr Patrick Yu Wai Man	Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation	2019
Selena Trifunov Dr Angela Pyle Dr Patrick Yu Wai Man Dr Florence Burte Dr Jennifer Duff et al.	Clonal expansion of mtDNA deletions: different disease models assessed by digital droplet PCR in single muscle cells	2018
Dr Florence Burte	Low plasma haptoglobin is a risk factor for life-threatening childhood severe malarial anemia and not an exclusive consequence of hemolysis	2018
Dr Florence Burte	A Functional IL22 Polymorphism (rs2227473) Is Associated with Predisposition to Childhood Cerebral Malaria	2017
David Moore Dr Florence Burte Dr Patrick Yu Wai Man	A novel CISD2 mutation associated with a classical Wolfram syndrome phenotype alters Ca2+ homeostasis and ER-mitochondria interactions	2017
David Moore Dr Florence Burte Dr Patrick Yu Wai Man	Corrigendum: A novel CISD2 mutation associated with a classical wolfram syndrome phenotype alters Ca21 homeostasis and ER-mitochondria interactions. [Human Molecular Genetics (2017)], doi: 10.1093/hmg/ddx060	2017
Dr Patrick Yu Wai Man David Moore Dr Florence Burte	Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy	2017
Dr Florence Burte Dr Dave Houghton Hannah Lowes Dr Angela Pyle Sarah Nesbitt et al.	Metabolic profiling of Parkinson's disease and mild cognitive impairment	2017
Dr Florence Burte Dr Patrick Yu Wai Man	CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis	2016
Dr Patrick Yu Wai Man Dr Florence Burte	A neurodegenerative perspective on mitochondrial optic neuropathies	2016
Padraig Flannery Dr Florence Burte Professor Robert Taylor Professor Laurence Bindoff Dr Patrick Yu Wai Man et al.	Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation	2016
Dr Florence Burte	The IL17F and IL17RA Genetic Variants Increase Risk of Cerebral Malaria in Two African Populations	2016
Dr Florence Burte Professor Patrick Chinnery Dr Patrick Yu Wai Man	Disturbed mitochondrial dynamics and neurodegenerative disorders	2015
Dr Florence Burte	Malaria Induces Anemia through CD8⁺ T Cell-Dependent Parasite Clearance and Erythrocyte Removal in the Spleen	2015
Dr Florence Burte	Affinity Proteomics Reveals Elevated Muscle Proteins in Plasma of Children with Cerebral Malaria	2014
Dr Florence Burte	Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria	2013
Dr Florence Burte	Severe childhood malaria syndromes defined by plasma proteome profiles	2012
Dr Florence Burte	Alterations in the mitochondrial proteome of neuroblastoma cells in response to complex I inhibition	2011